187 related articles for article (PubMed ID: 36006128)
1. Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoroalkyl Substances Using Artificial Intelligence.
Kaiser AM; Zare Jeddi M; Uhl M; Jornod F; Fernandez MF; Audouze K
Toxics; 2022 Aug; 10(8):. PubMed ID: 36006128
[TBL] [Abstract][Full Text] [Related]
2. AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways development.
Jornod F; Jaylet T; Blaha L; Sarigiannis D; Tamisier L; Audouze K
Bioinformatics; 2022 Jan; 38(4):1173-1175. PubMed ID: 34718414
[TBL] [Abstract][Full Text] [Related]
3. A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health.
Rogers JM; Heintz MM; Thompson CM; Haws LC
Birth Defects Res; 2023 Jun; 115(11):1011-1062. PubMed ID: 37219003
[TBL] [Abstract][Full Text] [Related]
4. AOP4EUpest: mapping of pesticides in adverse outcome pathways using a text mining tool.
Jornod F; Rugard M; Tamisier L; Coumoul X; Andersen HR; Barouki R; Audouze K
Bioinformatics; 2020 Aug; 36(15):4379-4381. PubMed ID: 32467965
[TBL] [Abstract][Full Text] [Related]
5. Reduced Birth Weight and Exposure to Per- and Polyfluoroalkyl Substances: A Review of Possible Underlying Mechanisms Using the AOP-HelpFinder.
Gundacker C; Audouze K; Widhalm R; Granitzer S; Forsthuber M; Jornod F; Wielsøe M; Long M; Halldórsson TI; Uhl M; Bonefeld-Jørgensen EC
Toxics; 2022 Nov; 10(11):. PubMed ID: 36422892
[TBL] [Abstract][Full Text] [Related]
6. Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach.
Carvaillo JC; Barouki R; Coumoul X; Audouze K
Environ Health Perspect; 2019 Apr; 127(4):47005. PubMed ID: 30994381
[TBL] [Abstract][Full Text] [Related]
7. AOP-helpFinder 2.0: Integration of an event-event searches module.
Jaylet T; Coustillet T; Jornod F; Margaritte-Jeannin P; Audouze K
Environ Int; 2023 Jul; 177():108017. PubMed ID: 37295163
[TBL] [Abstract][Full Text] [Related]
8. Baseline Toxicity Model to Identify the Specific and Nonspecific Effects of Per- and Polyfluoroalkyl Substances in Cell-Based Bioassays.
Qin W; Henneberger L; Glüge J; König M; Escher BI
Environ Sci Technol; 2024 Apr; 58(13):5727-5738. PubMed ID: 38394616
[TBL] [Abstract][Full Text] [Related]
9. An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly.
Jaylet T; Quintens R; Armant O; Audouze K
Front Cell Dev Biol; 2023; 11():1197204. PubMed ID: 37427375
[TBL] [Abstract][Full Text] [Related]
10. How to investigate human health effects related to exposure to mixtures of per- and polyfluoroalkyl substances: A systematic review of statistical methods.
Rosato I; Zare Jeddi M; Ledda C; Gallo E; Fletcher T; Pitter G; Batzella E; Canova C
Environ Res; 2022 Apr; 205():112565. PubMed ID: 34915031
[TBL] [Abstract][Full Text] [Related]
11. Association Between Exposure to Per- and Polyfluoroalkyl Substances and Birth Outcomes: A Systematic Review and Meta-Analysis.
Gui SY; Chen YN; Wu KJ; Liu W; Wang WJ; Liang HR; Jiang ZX; Li ZL; Hu CY
Front Public Health; 2022; 10():855348. PubMed ID: 35400049
[TBL] [Abstract][Full Text] [Related]
12. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects.
Blake BE; Fenton SE
Toxicology; 2020 Oct; 443():152565. PubMed ID: 32861749
[TBL] [Abstract][Full Text] [Related]
13. The PFAS-Tox Database: A systematic evidence map of health studies on 29 per- and polyfluoroalkyl substances.
Pelch KE; Reade A; Kwiatkowski CF; Merced-Nieves FM; Cavalier H; Schultz K; Wolffe T; Varshavsky J
Environ Int; 2022 Sep; 167():107408. PubMed ID: 35908389
[TBL] [Abstract][Full Text] [Related]
14. Semantic characterization of adverse outcome pathways.
Wang RL
Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
[TBL] [Abstract][Full Text] [Related]
15. Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429).
Tsamou M; Roggen EL
J Alzheimers Dis Rep; 2022; 6(1):271-296. PubMed ID: 35891639
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes by per- and polyfluoroalkyl substances (PFAS).
Kim S; Thapar I; Brooks BW
Environ Pollut; 2021 Jun; 279():116929. PubMed ID: 33751946
[TBL] [Abstract][Full Text] [Related]
17. Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials.
Martens M; Verbruggen T; Nymark P; Grafström R; Burgoon LD; Aladjov H; Torres Andón F; Evelo CT; Willighagen EL
Front Genet; 2018; 9():661. PubMed ID: 30622555
[TBL] [Abstract][Full Text] [Related]
18. Diet as an Exposure Source and Mediator of Per- and Polyfluoroalkyl Substance (PFAS) Toxicity.
Roth K; Imran Z; Liu W; Petriello MC
Front Toxicol; 2020; 2():601149. PubMed ID: 35296120
[TBL] [Abstract][Full Text] [Related]
19. Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOA.
Jane L Espartero L; Yamada M; Ford J; Owens G; Prow T; Juhasz A
Environ Res; 2022 Sep; 212(Pt C):113431. PubMed ID: 35569538
[TBL] [Abstract][Full Text] [Related]
20. AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.
Pittman ME; Edwards SW; Ives C; Mortensen HM
Toxicol Appl Pharmacol; 2018 Mar; 343():71-83. PubMed ID: 29454060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
